| |
| |
|
| Insider
Information: |
Ho Carole |
| Relationship: |
Chief Medical Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
143,605 |
|
|
Indirect Shares
|
208,219 |
|
|
| Direct
Value |
$2,629,408 |
|
|
|
Indirect Value
|
$3,812,490 |
|
|
| Total
Shares |
351,824 |
|
|
| Total
Value |
$6,441,897 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
12
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 13.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-02-14 |
143,605 |
2024-02-14 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2024-02-14 |
4 |
AS |
$17.79 |
$24,995 |
D/D |
(1,405) |
143,605 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2024-02-13 |
4 |
AS |
$17.29 |
$48,135 |
D/D |
(2,784) |
145,010 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2024-01-10 |
4 |
AS |
$19.02 |
$88,785 |
D/D |
(4,668) |
147,794 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2024-01-05 |
4 |
S |
$19.43 |
$193,756 |
I/I |
(9,972) |
198,777 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
53,720 |
162,434 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-23 |
4 |
AS |
$23.22 |
$58,561 |
I/I |
(2,522) |
182,809 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-21 |
4 |
S |
$22.60 |
$56,003 |
I/I |
(2,478) |
185,331 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-14 |
4 |
AS |
$23.79 |
$65,851 |
I/I |
(2,768) |
182,809 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-10 |
4 |
S |
$24.15 |
$68,997 |
I/I |
(2,857) |
185,577 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-02-15 |
4 |
AS |
$29.40 |
$43,394 |
I/I |
(1,476) |
182,809 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-02-13 |
4 |
AS |
$30.10 |
$76,695 |
I/I |
(2,548) |
184,285 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-02-10 |
4 |
AS |
$29.80 |
$24,376 |
I/I |
(818) |
179,365 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-02-08 |
4 |
S |
$30.88 |
$46,968 |
I/I |
(1,521) |
180,183 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-01-09 |
4 |
AS |
$28.48 |
$41,552 |
I/I |
(1,459) |
177,454 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-01-06 |
4 |
AS |
$28.67 |
$41,600 |
I/I |
(1,451) |
178,913 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-01-05 |
4 |
AS |
$28.44 |
$74,968 |
I/I |
(2,636) |
180,364 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-01-04 |
4 |
S |
$28.69 |
$83,574 |
I/I |
(2,913) |
175,500 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
41,120 |
138,967 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-08-23 |
4 |
AS |
$31.98 |
$77,520 |
I/I |
(2,424) |
170,663 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-08-19 |
4 |
S |
$33.22 |
$85,575 |
I/I |
(2,576) |
173,087 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
110,597 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-02-11 |
4 |
S |
$34.71 |
$101,284 |
I/I |
(2,918) |
170,663 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-02-09 |
4 |
S |
$37.10 |
$52,791 |
I/I |
(1,423) |
166,112 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-01-05 |
4 |
S |
$44.78 |
$127,399 |
I/I |
(2,845) |
163,285 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
107,316 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
